|
|
Volumn 292, Issue 5514, 2001, Pages 24-25
|
|
Merck reemerges with a bold AIDS vaccine effort
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
DNA VACCINE;
RECOMBINANT VACCINE;
SIMIAN IMMUNODEFICIENCY VIRUS VACCINE;
SMALLPOX VACCINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
DRUG INDUSTRY;
DRUG RESEARCH;
NOTE;
PRIORITY JOURNAL;
VACCINE PRODUCTION;
ADENOVIRUS;
ANIMAL;
ARTICLE;
GENE VECTOR;
GENETICS;
HAPLORHINI;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
IMMUNOLOGY;
KILLER CELL;
MONKEY DISEASE;
PHYSIOLOGY;
SIMIAN IMMUNODEFICIENCY VIRUS;
STRUCTURAL GENE;
VIROLOGY;
VIRUS LOAD;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ADENOVIRIDAE;
AIDS VACCINES;
ANIMALS;
DRUG INDUSTRY;
GENES, GAG;
GENETIC VECTORS;
HAPLORHINI;
HIV;
HUMANS;
KILLER CELLS;
SAIDS VACCINES;
SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME;
SIMIAN IMMUNODEFICIENCY VIRUS;
SMALLPOX VACCINE;
VACCINES, DNA;
VACCINES, SYNTHETIC;
VIRAL LOAD;
|
|
EID: 0035815386
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.292.5514.24 Document Type: Note |
|
Times cited : (21)
|
|
References (0)
|